NFKB1 and cystic fibrosis: It transports reduced glutathione conjugates, cysteinyl leukotriene LTC4, steroid glucoronides and bile salt derivatives in human cells, agents involved in the transcription factor NF-kB activation pathway, which has been reported to be altered in CF [12,13].